Chokri Bahloul

Title: Chokri Bahloul: Innovator in Immunogenic Research

Introduction

Chokri Bahloul is a prominent inventor based in Bards, TN. He has made significant contributions to the field of immunogenic research, holding a total of 4 patents. His work focuses on developing innovative solutions for enhancing immune responses, particularly in relation to rabies protection.

Latest Patents

One of his latest patents involves chimeric lyssavirus nucleic acids and polypeptides. This invention provides chimeric nucleic acids, preferably contained on an expression vector, that encode chimeric immunogenic polypeptides. The nucleic acids encode at least site III of a lyssavirus glycoprotein, which has been found to improve the immunogenicity of lyssavirus epitopes for protection from rabies. The chimeric nucleic acids and proteins can also contain antigenic determinants for epitopes other than those of lyssavirus. Thus, the invention provides chimeric nucleic acids and polypeptides that elicit a strong immune response to multiple antigens. The methods of this invention permit DNA vaccination without the need to supply multiple antigens on separate DNA molecules.

Career Highlights

Chokri Bahloul is associated with the Institut Pasteur, a renowned research institution known for its contributions to the field of microbiology and immunology. His work at this institution has allowed him to explore and develop groundbreaking technologies in immunogenic research.

Collaborations

He has collaborated with notable colleagues such as Yves Jacob and Pierre Perrin, contributing to the advancement of research in his field.

Conclusion

Chokri Bahloul's innovative work in the development of chimeric nucleic acids and polypeptides showcases his commitment to enhancing immunogenic responses. His contributions are vital in the ongoing fight against diseases like rabies, and his patents reflect his significant impact on the field of immunology.